PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature
Background. Recurrent endometrial cancer after definitive therapy is a lethal disease. Recently, immune checkpoint inhibitors (ICI) have improved the management of mismatch repair-deficient (MSI-H) endometrial cancer. Autoimmune side effects are known to occur with ICI. As a result, patients with pr...
Saved in:
Main Authors: | Amanda Ramos, Marcela del Carmen, Oladapo Yeku |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/3428945 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01) -
P-ANCA Systemic Vasculitis Induced by Brucellosis in an Elderly Male Patient
by: Mohammed Cheikh, et al.
Published: (2021-01-01) -
Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
by: van Leeuwen JR, et al.
Published: (2025-01-01) -
Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01) -
A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the Literature
by: Richard A. Lau, et al.
Published: (2017-01-01)